Raquel Montero Selected Research

Raquel Montero Research Topics

Disease

8	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 02/2014
7	Coenzyme Q10 Deficiency 01/2018 - 01/2007
4	Ataxia (Dyssynergia) 02/2018 - 07/2010
3	Friedreich Ataxia (Friedreich's Ataxia) 11/2021 - 11/2008
3	Brain Diseases (Brain Disorder) 01/2020 - 12/2010
2	Cerebellar Diseases (Cerebellar Syndrome) 01/2019 - 02/2018
2	Kearns-Sayre Syndrome 11/2018 - 12/2014
2	Atrophy 01/2017 - 01/2017
2	Mucopolysaccharidoses 01/2016 - 10/2011
2	Congenital Disorders of Glycosylation 08/2009 - 03/2009
1	Cognitive Dysfunction 01/2020
1	Muscular Diseases (Myopathy) 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Lactic Acidosis 01/2020
1	Rhabdomyolysis 01/2020
1	Asthenia 01/2019
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2019
1	Stroke (Strokes) 02/2018
1	Channelopathies 02/2018
1	Migraine with Aura (Familial Hemiplegic Migraine) 02/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Inflammation (Inflammations) 03/2016
1	Myositis (Idiopathic Inflammatory Myopathies) 03/2016
1	Inclusion Body Myositis 03/2016
1	Dysarthria (Spastic Dysarthria) 11/2014
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 11/2014
1	Starvation 02/2014
1	Mitochondrial Encephalomyopathies (Mitochondrial Encephalomyopathy) 02/2014
1	Mitochondrial Myopathies (Mitochondrial Myopathy) 02/2014
1	Mucopolysaccharidosis III (Sanfilippo Syndrome) 10/2011
1	Cardiomegaly (Heart Hypertrophy) 03/2011
1	Neurologic Manifestations (Neurological Manifestations) 03/2011
1	Neutropenia 03/2011
1	Nervous System Diseases (Neurological Disorders) 12/2010
1	Cardiomyopathies (Cardiomyopathy) 11/2008
1	Leigh Disease (Leigh's Disease) 01/2007
1	Cerebellar Ataxia (Dysmetria) 01/2007

Drug/Important Bio-Agent (IBA)

8	coenzyme Q10 (CoQ10)IBA 01/2018 - 07/2010
6	Mitochondrial DNA (mtDNA)IBA 01/2021 - 05/2009
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2014
4	phosphomannomutaseIBA 01/2019 - 01/2017
3	idebenoneIBA 11/2021 - 11/2008
3	Growth Differentiation Factor 15IBA 01/2020 - 02/2014
3	Congenital disorder of glycosylation type 1AIBA 01/2019 - 01/2017
3	EnzymesIBA 01/2016 - 01/2007
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2016
2	voltage-dependent calcium channel (P-Q type)IBA 01/2019 - 02/2018
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2018 - 12/2014
2	Glucose (Dextrose)FDA LinkGeneric 11/2014 - 02/2014
2	UbiquinoneIBA 07/2010 - 01/2007
2	Transferrin (beta 2 Transferrin)IBA 08/2009 - 03/2009
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2019
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 11/2018
1	Biogenic Amines (Biogenic Amine)IBA 11/2018
1	PterinsIBA 11/2018
1	Pyruvic Acid (Pyruvate)IBA 03/2016
1	Amyloid (Amyloid Fibrils)IBA 03/2016
1	Oxidoreductases (Dehydrogenase)IBA 03/2016
1	Peptides (Polypeptides)IBA 03/2016
1	GlycosaminoglycansIBA 01/2016
1	fibroblast growth factor 21IBA 01/2016
1	Pyridoxal Phosphate (Pyridoxal 5 Phosphate)IBA 01/2016
1	Leucovorin (Folinic Acid)FDA Link 12/2014
1	LipidsIBA 11/2014
1	GlycogenIBA 02/2014
1	thymidine kinase 2IBA 02/2014
1	Heparitin Sulfate (Heparan Sulfate)IBA 10/2011
1	DeferiproneIBA 03/2011
1	Chelating AgentsIBA 03/2011
1	IronIBA 03/2011
1	Serotonin (5 Hydroxytryptamine)IBA 12/2010
1	AcidsIBA 12/2010
1	Hydroxyindoleacetic AcidIBA 12/2010
1	Coenzymes (Enzyme Cofactors)IBA 07/2010
1	AntioxidantsIBA 11/2008

Therapy/Procedure

4	Therapeutics 03/2011 - 01/2007
1	Ketogenic Diet 11/2014